[Click to access protein entry]
Spot: 2D-001YF6 (lymphocyte_human)
pI: 6.63 Mw: 18327
%vol: 0.397578 %od: 0.356968
================
*COF1_HUMAN*
accession n°: P23528
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)AVLFCLSEDKK(N);; $m/Z=(K)MoxLPDKDCR(Y);; $m/Z=(R)YALYDATYETK(E) }
Spot: 2D-001YF6 (lymphocyte_human)
pI: 6.63 Mw: 18327
%vol: 0.397578 %od: 0.356968
================
*COF1_HUMAN*
accession n°: P23528
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)AVLFCLSEDKK(N);; $m/Z=(K)MoxLPDKDCR(Y);; $m/Z=(R)YALYDATYETK(E) }
[Click to access protein entry]
Spot: 2D-001YA2 (lymphocyte_human)
pI: 7.92 Mw: 32277
%vol: 0.346644 %od: 0.367951
================
*VDAC2_HUMAN*
accession n°: P45880
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 940.46628 (0), 1293.64928 (0), 1428.66828 (0), 2103.16928 (0),
2528.22428 (0) }
Spot: 2D-001YA2 (lymphocyte_human)
pI: 7.92 Mw: 32277
%vol: 0.346644 %od: 0.367951
================
*VDAC2_HUMAN*
accession n°: P45880
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 940.46628 (0), 1293.64928 (0), 1428.66828 (0), 2103.16928 (0),
2528.22428 (0) }
[Click to access protein entry]
Spot: 2D-001YBO (lymphocyte_human)
pI: 5.47 Mw: 28216
%vol: 0.158915 %od: 0.137231
================
*CAPZB_HUMAN*
accession n°: P47756
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1057.59928 (0), 1108.63728 (0), 1171.58028 (0), 1231.54828 (0),
1534.67928 (0), 1568.71428 (0), 1696.82928 (0)
}
Spot: 2D-001YBO (lymphocyte_human)
pI: 5.47 Mw: 28216
%vol: 0.158915 %od: 0.137231
================
*CAPZB_HUMAN*
accession n°: P47756
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1057.59928 (0), 1108.63728 (0), 1171.58028 (0), 1231.54828 (0),
1534.67928 (0), 1568.71428 (0), 1696.82928 (0)
}
[Click to access protein entry]
Spot: 2D-001Y35 (lymphocyte_human)
pI: 7.37 Mw: 42232
%vol: 0.409221 %od: 0.705379
================
*ENOA_HUMAN*
accession n°: P06733
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1143.5926 (0), 1425.6797 (0), 1556.7592 (0), 1804.9472 (0),
1939.978 (0), 1960.9184 (0) }
Spot: 2D-001Y35 (lymphocyte_human)
pI: 7.37 Mw: 42232
%vol: 0.409221 %od: 0.705379
================
*ENOA_HUMAN*
accession n°: P06733
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1143.5926 (0), 1425.6797 (0), 1556.7592 (0), 1804.9472 (0),
1939.978 (0), 1960.9184 (0) }
[Click to access protein entry]
Spot: 2D-001YE9 (lymphocyte_human)
pI: 7.53 Mw: 22696
%vol: 0.120787 %od: 0.0999226
================
*SODM_HUMAN*
accession n°: P04179
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 971.43579 (0), 1004.5364 (0), 1028.5896 (0), 1090.4984 (0),
1424.7871 (0), 1738.8435 (0) }
Spot: 2D-001YE9 (lymphocyte_human)
pI: 7.53 Mw: 22696
%vol: 0.120787 %od: 0.0999226
================
*SODM_HUMAN*
accession n°: P04179
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 971.43579 (0), 1004.5364 (0), 1028.5896 (0), 1090.4984 (0),
1424.7871 (0), 1738.8435 (0) }
[Click to access protein entry]
Spot: 2D-001YDC (lymphocyte_human)
pI: 7.00 Mw: 25098
%vol: 0.148146 %od: 0.0936055
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1082.5862 (0), 1234.6576 (0), 1458.7059 (0), 1466.7165 (0),
1586.7503 (0), 1614.8234 (0), 2192.068 (0) }
Spot: 2D-001YDC (lymphocyte_human)
pI: 7.00 Mw: 25098
%vol: 0.148146 %od: 0.0936055
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1082.5862 (0), 1234.6576 (0), 1458.7059 (0), 1466.7165 (0),
1586.7503 (0), 1614.8234 (0), 2192.068 (0) }
[Click to access protein entry]
Spot: 2D-001YGB (lymphocyte_human)
pI: 7.94 Mw: 16072
%vol: 0.0855696 %od: 0.112979
================
*DOPD_HUMAN*
accession n°: P30046
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)SHSAHFFEFLTK(E);; $m/Z=(-)PFLELDTNLPANR(V) }
Spot: 2D-001YGB (lymphocyte_human)
pI: 7.94 Mw: 16072
%vol: 0.0855696 %od: 0.112979
================
*DOPD_HUMAN*
accession n°: P30046
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)SHSAHFFEFLTK(E);; $m/Z=(-)PFLELDTNLPANR(V) }
[Click to access protein entry]
Spot: 2D-001Y0C (lymphocyte_human)
pI: 4.49 Mw: 43286
%vol: 0.162408 %od: 0.167122
================
*LSP1_HUMAN*
accession n°: P33241
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1647.8418 (0), 1974.9857 (0), 1977.9033 (0), 2022.001 (0),
2064.9292 (0), 2864.1504 (0) }
Spot: 2D-001Y0C (lymphocyte_human)
pI: 4.49 Mw: 43286
%vol: 0.162408 %od: 0.167122
================
*LSP1_HUMAN*
accession n°: P33241
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1647.8418 (0), 1974.9857 (0), 1977.9033 (0), 2022.001 (0),
2064.9292 (0), 2864.1504 (0) }
[Click to access protein entry]
Spot: 2D-001YH7 (lymphocyte_human)
pI: 4.22 Mw: 16594
================
*CALM_HUMAN*
accession n°: P62158
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.49 (0), 1265.64 (0), 1596.72 (0), 1754.88 (0), 1844.9 (0)
}
Spot: 2D-001YH7 (lymphocyte_human)
pI: 4.22 Mw: 16594
================
*CALM_HUMAN*
accession n°: P62158
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.49 (0), 1265.64 (0), 1596.72 (0), 1754.88 (0), 1844.9 (0)
}
[Click to access protein entry]
Spot: 2D-001YD5 (lymphocyte_human)
pI: 6.73 Mw: 25482
%vol: 0.273299 %od: 0.173726
================
*PRDX6_HUMAN*
accession n°: P30041
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 906.4809 (0), 1045.564 (0), 1085.6079 (0), 1191.692 (0),
1395.6768 (0), 2098.0915 (0) }
Spot: 2D-001YD5 (lymphocyte_human)
pI: 6.73 Mw: 25482
%vol: 0.273299 %od: 0.173726
================
*PRDX6_HUMAN*
accession n°: P30041
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 906.4809 (0), 1045.564 (0), 1085.6079 (0), 1191.692 (0),
1395.6768 (0), 2098.0915 (0) }
[Click to access protein entry]
Spot: 2D-001YF9 (lymphocyte_human)
pI: 5.44 Mw: 18173
%vol: 0.0445311 %od: 0.035652
================
*ARPC5_HUMAN*
accession n°: O15511
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)GFESPSDNSSAMoxLLQWHEK(A);; $m/Z=(K)ALAAGGVGSIVR(V);; $m/Z=(R)QGNMoxTAALQAALK(N) }
Spot: 2D-001YF9 (lymphocyte_human)
pI: 5.44 Mw: 18173
%vol: 0.0445311 %od: 0.035652
================
*ARPC5_HUMAN*
accession n°: O15511
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)GFESPSDNSSAMoxLLQWHEK(A);; $m/Z=(K)ALAAGGVGSIVR(V);; $m/Z=(R)QGNMoxTAALQAALK(N) }
[Click to access protein entry]
Spot: 2D-001YH8 (lymphocyte_human)
pI: 6.74 Mw: 20794
================
*STMN1_HUMAN*
accession n°: P16949
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)ASGQAFELILSPR(S) }
Spot: 2D-001YH8 (lymphocyte_human)
pI: 6.74 Mw: 20794
================
*STMN1_HUMAN*
accession n°: P16949
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)ASGQAFELILSPR(S) }
[Click to access protein entry]
Spot: 2D-001Y0H (lymphocyte_human)
pI: 4.99 Mw: 43286
%vol: 0.274754 %od: 0.356813
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)RQVDQLTNDK(A);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(R)FANYIDK(V);; $m/Z=(R)TYSLGSALRPSTSR(S);; $m/Z=(K)MALDIEIATYR(K);; $m/Z=(K)LLEGEESR(I);; $m/Z=(R)QVQSLTCEVDALK(G);; $m/Z=(K)FADLSEAANR(N);; $m/Z=(R)QQYESVAAK(N);; $m/Z=(K)LQEEMLQR(E);; $m/Z=(R)QVDQLTNDK(A) }
================
*DESM_HUMAN*
accession n: P17661
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)LLEGEESR(I);; $m/Z=(R)KLLEGEESR(I);; $m/Z=(R)VSSYRR(T) }
Spot: 2D-001Y0H (lymphocyte_human)
pI: 4.99 Mw: 43286
%vol: 0.274754 %od: 0.356813
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)RQVDQLTNDK(A);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(R)FANYIDK(V);; $m/Z=(R)TYSLGSALRPSTSR(S);; $m/Z=(K)MALDIEIATYR(K);; $m/Z=(K)LLEGEESR(I);; $m/Z=(R)QVQSLTCEVDALK(G);; $m/Z=(K)FADLSEAANR(N);; $m/Z=(R)QQYESVAAK(N);; $m/Z=(K)LQEEMLQR(E);; $m/Z=(R)QVDQLTNDK(A) }
================
*DESM_HUMAN*
accession n: P17661
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)LLEGEESR(I);; $m/Z=(R)KLLEGEESR(I);; $m/Z=(R)VSSYRR(T) }
[Click to access protein entry]
Spot: 2D-001YD3 (lymphocyte_human)
pI: 4.81 Mw: 25592
%vol: 0.123116 %od: 0.0782156
================
*CPNS1_HUMAN*
accession n°: P04632
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)THYSNIEANESEEVR(Q);; $m/Z=(K)TDGFGIDTCR(S) }
Spot: 2D-001YD3 (lymphocyte_human)
pI: 4.81 Mw: 25592
%vol: 0.123116 %od: 0.0782156
================
*CPNS1_HUMAN*
accession n°: P04632
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)THYSNIEANESEEVR(Q);; $m/Z=(K)TDGFGIDTCR(S) }
[Click to access protein entry]
Spot: 2D-001YH2 (lymphocyte_human)
pI: 8.02 Mw: 15000
%vol: 0.0238663 %od: 0.0217901
================
*S10AA_HUMAN*
accession n°: P60903
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)EFPGFLENQKDPLAVDK(I);; $m/Z=(K)EFPGFLENQK(D) }
Spot: 2D-001YH2 (lymphocyte_human)
pI: 8.02 Mw: 15000
%vol: 0.0238663 %od: 0.0217901
================
*S10AA_HUMAN*
accession n°: P60903
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)EFPGFLENQKDPLAVDK(I);; $m/Z=(K)EFPGFLENQK(D) }
[Click to access protein entry]
Spot: 2D-001YBL (lymphocyte_human)
pI: 5.10 Mw: 28586
%vol: 0.401362 %od: 0.392965
================
*CLIC1_HUMAN*
accession n°: O00299
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 957.49928 (0), 1037.56028 (0), 1095.64428 (0), 1844.97428 (0),
2233.07628 (0) }
Spot: 2D-001YBL (lymphocyte_human)
pI: 5.10 Mw: 28586
%vol: 0.401362 %od: 0.392965
================
*CLIC1_HUMAN*
accession n°: O00299
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 957.49928 (0), 1037.56028 (0), 1095.64428 (0), 1844.97428 (0),
2233.07628 (0) }
[Click to access protein entry]
Spot: 2D-001YG4 (lymphocyte_human)
pI: 7.11 Mw: 16455
%vol: 0.0279411 %od: 0.0270651
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)ISGLIYEETR(G);; $m/Z=(R)DNIQGITKPAIR(R);; $m/Z=(K)VFLENVIR(D) }
Spot: 2D-001YG4 (lymphocyte_human)
pI: 7.11 Mw: 16455
%vol: 0.0279411 %od: 0.0270651
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)ISGLIYEETR(G);; $m/Z=(R)DNIQGITKPAIR(R);; $m/Z=(K)VFLENVIR(D) }
[Click to access protein entry]
Spot: 2D-001Y2I (lymphocyte_human)
pI: 4.97 Mw: 42552
%vol: 0.481402 %od: 0.852539
================
*ATPB_HUMAN*
accession n°: P06576
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 975.46428 (0), 1038.5 (0), 1262.5659 (0), 1278.6003 (0),
1385.6373 (0), 1401.6378 (0), 1406.6121 (0), 1435.6911 (0),
1439.7253 (0), 1601.7664 (0), 1617.7455 (0), 1650.8752 (0),
1815.8459 (0), 1831.8573 (0), 1919.0973 (0), 1921.9578 (0),
1988.0279 (0), 2039.022 (0), 2266.1179 (0), 2282.1443 (0),
2675.4246 (0) }
Spot: 2D-001Y2I (lymphocyte_human)
pI: 4.97 Mw: 42552
%vol: 0.481402 %od: 0.852539
================
*ATPB_HUMAN*
accession n°: P06576
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 975.46428 (0), 1038.5 (0), 1262.5659 (0), 1278.6003 (0),
1385.6373 (0), 1401.6378 (0), 1406.6121 (0), 1435.6911 (0),
1439.7253 (0), 1601.7664 (0), 1617.7455 (0), 1650.8752 (0),
1815.8459 (0), 1831.8573 (0), 1919.0973 (0), 1921.9578 (0),
1988.0279 (0), 2039.022 (0), 2266.1179 (0), 2282.1443 (0),
2675.4246 (0) }
[Click to access protein entry]
Spot: 2D-001YDQ (lymphocyte_human)
pI: 5.03 Mw: 23952
%vol: 0.374585 %od: 0.646581
================
*GDIR2_HUMAN*
accession n°: P52566
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 855.49563 (0), 966.47328 (0), 967.47607 (0), 1084.5995 (0),
1311.7 (0), 1692.781 (0), 1708.7637 (0), 1939.7943 (0)
}
Spot: 2D-001YDQ (lymphocyte_human)
pI: 5.03 Mw: 23952
%vol: 0.374585 %od: 0.646581
================
*GDIR2_HUMAN*
accession n°: P52566
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 855.49563 (0), 966.47328 (0), 967.47607 (0), 1084.5995 (0),
1311.7 (0), 1692.781 (0), 1708.7637 (0), 1939.7943 (0)
}
[Click to access protein entry]
Spot: 2D-001Y7K (lymphocyte_human)
pI: 7.89 Mw: 37732
%vol: 0.334711 %od: 0.415566
================
*ALDOA_HUMAN*
accession n°: P04075
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1068.5528 (0), 1093.5656 (0), 1342.7089 (0), 1646.8045 (0),
1675.8394 (0), 1691.8279 (0), 2107.1055 (0), 2123.107 (0),
3176.6785 (0) }
Spot: 2D-001Y7K (lymphocyte_human)
pI: 7.89 Mw: 37732
%vol: 0.334711 %od: 0.415566
================
*ALDOA_HUMAN*
accession n°: P04075
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1068.5528 (0), 1093.5656 (0), 1342.7089 (0), 1646.8045 (0),
1675.8394 (0), 1691.8279 (0), 2107.1055 (0), 2123.107 (0),
3176.6785 (0) }
[Click to access protein entry]
Spot: 2D-001YDL (lymphocyte_human)
pI: 6.00 Mw: 24400
%vol: 0.0654869 %od: 0.0320329
================
*GRB2_HUMAN*
accession n°: P62993
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 918.51121 (0), 928.46921 (0), 962.48723 (0), 1091.5116 (0),
1212.6374 (0), 1452.678 (0), 1506.7351 (0) }
Spot: 2D-001YDL (lymphocyte_human)
pI: 6.00 Mw: 24400
%vol: 0.0654869 %od: 0.0320329
================
*GRB2_HUMAN*
accession n°: P62993
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 918.51121 (0), 928.46921 (0), 962.48723 (0), 1091.5116 (0),
1212.6374 (0), 1452.678 (0), 1506.7351 (0) }
[Click to access protein entry]
Spot: 2D-001YG7 (lymphocyte_human)
pI: 4.94 Mw: 16289
%vol: 0.104779 %od: 0.0513232
================
*LEG1_HUMAN*
accession n°: P09382
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)VRGEVAPDAK(S);; $m/Z=(K)SFVLNLGK(D);; $m/Z=(K)DSNNLCLHFNPR(F);; $m/Z=(K)DGGAWGTEQR(E);; $m/Z=(R)FNAHGDANTIVCNSK(D);; $m/Z=(K)LPDGYEFK(F) }
Spot: 2D-001YG7 (lymphocyte_human)
pI: 4.94 Mw: 16289
%vol: 0.104779 %od: 0.0513232
================
*LEG1_HUMAN*
accession n°: P09382
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)VRGEVAPDAK(S);; $m/Z=(K)SFVLNLGK(D);; $m/Z=(K)DSNNLCLHFNPR(F);; $m/Z=(K)DGGAWGTEQR(E);; $m/Z=(R)FNAHGDANTIVCNSK(D);; $m/Z=(K)LPDGYEFK(F) }
[Click to access protein entry]
Spot: 2D-001YD7 (lymphocyte_human)
pI: 7.38 Mw: 25207
%vol: 0.45317 %od: 0.579549
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 954.4686 (0), 1082.5631 (0), 1137.5636 (0), 1234.6166 (0),
1326.6824 (0), 1458.7152 (0), 1466.7069 (0), 1542.8403 (0),
1586.7368 (0), 1602.776 (0), 1614.8172 (0), 1637.7974 (0),
2192.061 (0) }
Spot: 2D-001YD7 (lymphocyte_human)
pI: 7.38 Mw: 25207
%vol: 0.45317 %od: 0.579549
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 954.4686 (0), 1082.5631 (0), 1137.5636 (0), 1234.6166 (0),
1326.6824 (0), 1458.7152 (0), 1466.7069 (0), 1542.8403 (0),
1586.7368 (0), 1602.776 (0), 1614.8172 (0), 1637.7974 (0),
2192.061 (0) }
[Click to access protein entry]
Spot: 2D-001YCK (lymphocyte_human)
pI: 4.55 Mw: 26669
%vol: 0.121951 %od: 0.125594
================
*PSA5_HUMAN*
accession n°: P28066
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)GPQLFHMoxDPSGTFVQCDAR(A);; $m/Z=(K)LNATNIELATVQPGQNFHMoxFTK(E);; $m/Z=(R)ITSPLMEPSSIEK(I);; $m/Z=(R)ITSPLMoxEPSSIEK(I);; $m/Z=(K)IVEIDAHIGCAMoxSGLIADAK(T);; $m/Z=(R)AIGSASEGAQSSLQEVYHK(S) }
Spot: 2D-001YCK (lymphocyte_human)
pI: 4.55 Mw: 26669
%vol: 0.121951 %od: 0.125594
================
*PSA5_HUMAN*
accession n°: P28066
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)GPQLFHMoxDPSGTFVQCDAR(A);; $m/Z=(K)LNATNIELATVQPGQNFHMoxFTK(E);; $m/Z=(R)ITSPLMEPSSIEK(I);; $m/Z=(R)ITSPLMoxEPSSIEK(I);; $m/Z=(K)IVEIDAHIGCAMoxSGLIADAK(T);; $m/Z=(R)AIGSASEGAQSSLQEVYHK(S) }
[Click to access protein entry]
Spot: 2D-001YGK (lymphocyte_human)
pI: 6.90 Mw: 15777
%vol: 0.0555911 %od: 0.0406711
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)VFLENVIR(D);; $m/Z=(R)DNIQGITKPAIR(R);; $m/Z=(R)DAVTYTEHAK(R);; $m/Z=(R)ISGLIYEETR(G) }
Spot: 2D-001YGK (lymphocyte_human)
pI: 6.90 Mw: 15777
%vol: 0.0555911 %od: 0.0406711
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)VFLENVIR(D);; $m/Z=(R)DNIQGITKPAIR(R);; $m/Z=(R)DAVTYTEHAK(R);; $m/Z=(R)ISGLIYEETR(G) }
[Click to access protein entry]
Spot: 2D-001YFY (lymphocyte_human)
pI: 5.16 Mw: 16734
%vol: 0.0101869 %od: 0.00445649
================
*TBCA_HUMAN*
accession n°: O75347
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)LEAAYLDLQR(I);; $m/Z=(K)QAEILQESR(M);; $m/Z=(R)RLEAAYLDLQR(I) }
================
*H2A1J_HUMAN*
accession n: P99059
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)AGLQFPVGR(V);; $m/Z=(R)HLQLAIR(N) }
Spot: 2D-001YFY (lymphocyte_human)
pI: 5.16 Mw: 16734
%vol: 0.0101869 %od: 0.00445649
================
*TBCA_HUMAN*
accession n°: O75347
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)LEAAYLDLQR(I);; $m/Z=(K)QAEILQESR(M);; $m/Z=(R)RLEAAYLDLQR(I) }
================
*H2A1J_HUMAN*
accession n: P99059
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)AGLQFPVGR(V);; $m/Z=(R)HLQLAIR(N) }
[Click to access protein entry]
Spot: 2D-001YG3 (lymphocyte_human)
pI: 4.75 Mw: 16427
%vol: 0.0791664 %od: 0.0611696
================
*COX5A_HUMAN*
accession n°: P20674
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1607.6572 (0), 1692.8538 (0), 2052.9844 (0), 3428.8217 (0)
}
Spot: 2D-001YG3 (lymphocyte_human)
pI: 4.75 Mw: 16427
%vol: 0.0791664 %od: 0.0611696
================
*COX5A_HUMAN*
accession n°: P20674
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1607.6572 (0), 1692.8538 (0), 2052.9844 (0), 3428.8217 (0)
}
[Click to access protein entry]
Spot: 2D-001XZ0 (lymphocyte_human)
pI: 5.40 Mw: 43724
%vol: 0.40631 %od: 0.242677
================
*TCPE_HUMAN*
accession n°: P48643
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.5052 (0), 1183.6678 (0), 1274.6411 (0), 1610.8752 (0),
1738.9072 (0) }
Spot: 2D-001XZ0 (lymphocyte_human)
pI: 5.40 Mw: 43724
%vol: 0.40631 %od: 0.242677
================
*TCPE_HUMAN*
accession n°: P48643
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.5052 (0), 1183.6678 (0), 1274.6411 (0), 1610.8752 (0),
1738.9072 (0) }
[Click to access protein entry]
Spot: 2D-001Y0Q (lymphocyte_human)
pI: 5.70 Mw: 43221
%vol: 0.487514 %od: 0.379608
================
*PDIA3_HUMAN*
accession n°: P30101
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 869.4443 (0), 877.4562 (0), 995.5615 (0), 1084.5668 (0),
1172.5655 (0), 1188.536 (0), 1191.6128 (0), 1236.5323 (0),
1341.678 (0), 1359.6649 (0), 1370.7103 (0), 1515.8008 (0),
1680.8153 (0), 2575.3526 (0), 2703.3885 (0) }
Spot: 2D-001Y0Q (lymphocyte_human)
pI: 5.70 Mw: 43221
%vol: 0.487514 %od: 0.379608
================
*PDIA3_HUMAN*
accession n°: P30101
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 869.4443 (0), 877.4562 (0), 995.5615 (0), 1084.5668 (0),
1172.5655 (0), 1188.536 (0), 1191.6128 (0), 1236.5323 (0),
1341.678 (0), 1359.6649 (0), 1370.7103 (0), 1515.8008 (0),
1680.8153 (0), 2575.3526 (0), 2703.3885 (0) }
[Click to access protein entry]
Spot: 2D-001YFD (lymphocyte_human)
pI: 7.82 Mw: 17900
%vol: 0.352465 %od: 0.412426
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1055.5352 (0), 1154.5587 (0), 1247.6071 (0), 1310.5507 (0),
1379.7348 (0), 1423.735 (0), 1537.7165 (0), 1614.7363 (0),
1831.906 (0), 1946.0415 (0) }
Spot: 2D-001YFD (lymphocyte_human)
pI: 7.82 Mw: 17900
%vol: 0.352465 %od: 0.412426
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1055.5352 (0), 1154.5587 (0), 1247.6071 (0), 1310.5507 (0),
1379.7348 (0), 1423.735 (0), 1537.7165 (0), 1614.7363 (0),
1831.906 (0), 1946.0415 (0) }
[Click to access protein entry]
Spot: 2D-001Y97 (lymphocyte_human)
pI: 8.23 Mw: 34075
%vol: 0.448222 %od: 1.58791
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1799.0071 (0), 1880.0531 (0), 1927.0633 (0), 2189.9327 (0),
2205.9229 (0), 2220.0717 (0), 2495.0023 (0) }
Spot: 2D-001Y97 (lymphocyte_human)
pI: 8.23 Mw: 34075
%vol: 0.448222 %od: 1.58791
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1799.0071 (0), 1880.0531 (0), 1927.0633 (0), 2189.9327 (0),
2205.9229 (0), 2220.0717 (0), 2495.0023 (0) }
[Click to access protein entry]
Spot: 2D-001YF1 (lymphocyte_human)
pI: 5.73 Mw: 18638
%vol: 0.112929 %od: 0.0598397
================
*SODC_HUMAN*
accession n°: P00441
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)HVGDLGNVTADK(D);; $m/Z=(K)GDGPVQGIINFEQK(E) }
Spot: 2D-001YF1 (lymphocyte_human)
pI: 5.73 Mw: 18638
%vol: 0.112929 %od: 0.0598397
================
*SODC_HUMAN*
accession n°: P00441
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)HVGDLGNVTADK(D);; $m/Z=(K)GDGPVQGIINFEQK(E) }
[Click to access protein entry]
Spot: 2D-001YDK (lymphocyte_human)
pI: 5.47 Mw: 24400
%vol: 0.0553001 %od: 0.0305624
================
*PSB4_HUMAN*
accession n°: P28070
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-001YDK (lymphocyte_human)
pI: 5.47 Mw: 24400
%vol: 0.0553001 %od: 0.0305624
================
*PSB4_HUMAN*
accession n°: P28070
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-001YG9 (lymphocyte_human)
pI: 7.55 Mw: 16153
%vol: 0.098667 %od: 0.0696415
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* NORMAL LEVEL, MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1126.5561 (0), 1274.733 (0), 1314.6739 (0), 1669.883 (0)
}
Spot: 2D-001YG9 (lymphocyte_human)
pI: 7.55 Mw: 16153
%vol: 0.098667 %od: 0.0696415
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* NORMAL LEVEL, MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1126.5561 (0), 1274.733 (0), 1314.6739 (0), 1669.883 (0)
}
[Click to access protein entry]
Spot: 2D-001YDB (lymphocyte_human)
pI: 7.24 Mw: 25043
%vol: 0.248559 %od: 0.196872
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 954.4686 (0), 1082.5631 (0), 1137.5636 (0), 1234.6166 (0),
1326.6824 (0), 1458.7152 (0), 1466.7069 (0), 1542.8403 (0),
1586.7368 (0), 1614.8172 (0), 2192.061 (0) }
Spot: 2D-001YDB (lymphocyte_human)
pI: 7.24 Mw: 25043
%vol: 0.248559 %od: 0.196872
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 954.4686 (0), 1082.5631 (0), 1137.5636 (0), 1234.6166 (0),
1326.6824 (0), 1458.7152 (0), 1466.7069 (0), 1542.8403 (0),
1586.7368 (0), 1614.8172 (0), 2192.061 (0) }
[Click to access protein entry]
Spot: 2D-001YGX (lymphocyte_human)
pI: 6.83 Mw: 15152
%vol: 0.0235753 %od: 0.0136892
================
*B2MG_HUMAN*
accession n°: P61769
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)VNHVTLSQPK(I);; $m/Z=(K)VEHSDLSFSK(D) }
Spot: 2D-001YGX (lymphocyte_human)
pI: 6.83 Mw: 15152
%vol: 0.0235753 %od: 0.0136892
================
*B2MG_HUMAN*
accession n°: P61769
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)VNHVTLSQPK(I);; $m/Z=(K)VEHSDLSFSK(D) }
[Click to access protein entry]
Spot: 2D-001YG0 (lymphocyte_human)
pI: 7.63 Mw: 16594
%vol: 0.227604 %od: 0.198777
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* NORMAL LEVEL, MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1126.6138 (0), 1274.7705 (0), 1314.7063 (0), 1378.7344 (0),
1669.9066 (0), 1776.9864 (0), 1797.9638 (0), 2074.9416 (0)
}
Spot: 2D-001YG0 (lymphocyte_human)
pI: 7.63 Mw: 16594
%vol: 0.227604 %od: 0.198777
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* NORMAL LEVEL, MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1126.6138 (0), 1274.7705 (0), 1314.7063 (0), 1378.7344 (0),
1669.9066 (0), 1776.9864 (0), 1797.9638 (0), 2074.9416 (0)
}
[Click to access protein entry]
Spot: 2D-001YFN (lymphocyte_human)
pI: 4.35 Mw: 17424
%vol: 0.0980849 %od: 0.0465021
================
*MYL6_HUMAN*
accession n°: P60660
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1025.5118 (0), 1354.731 (0), 1544.674 (0), 1786.789 (0),
1904.0164 (0) }
Spot: 2D-001YFN (lymphocyte_human)
pI: 4.35 Mw: 17424
%vol: 0.0980849 %od: 0.0465021
================
*MYL6_HUMAN*
accession n°: P60660
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1025.5118 (0), 1354.731 (0), 1544.674 (0), 1786.789 (0),
1904.0164 (0) }
[Click to access protein entry]
Spot: 2D-001YGW (lymphocyte_human)
pI: 5.42 Mw: 15461
%vol: 0.213051 %od: 0.295567
================
*S10A4_HUMAN*
accession n°: P26447
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 890.48408 (0), 1049.5066 (0), 1065.5346 (0), 1247.6626 (0),
1263.6426 (0) }
Spot: 2D-001YGW (lymphocyte_human)
pI: 5.42 Mw: 15461
%vol: 0.213051 %od: 0.295567
================
*S10A4_HUMAN*
accession n°: P26447
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 890.48408 (0), 1049.5066 (0), 1065.5346 (0), 1247.6626 (0),
1263.6426 (0) }
[Click to access protein entry]
Spot: 2D-001YCI (lymphocyte_human)
pI: 7.33 Mw: 26611
%vol: 0.162699 %od: 0.123529
================
*PGAM1_HUMAN*
accession n°: P18669
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1059.5708 (0), 1150.6889 (0), 1312.6147 (0), 2115.0706 (0),
2131.1075 (0) }
Spot: 2D-001YCI (lymphocyte_human)
pI: 7.33 Mw: 26611
%vol: 0.162699 %od: 0.123529
================
*PGAM1_HUMAN*
accession n°: P18669
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1059.5708 (0), 1150.6889 (0), 1312.6147 (0), 2115.0706 (0),
2131.1075 (0) }
[Click to access protein entry]
Spot: 2D-001Y94 (lymphocyte_human)
pI: 7.86 Mw: 34149
%vol: 0.229641 %od: 0.685801
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1013.44 (0), 1050.42 (0), 1188.63 (0), 1377.63 (0), 1410.68 (0),
1798.93 (0), 1927.01 (0) }
Spot: 2D-001Y94 (lymphocyte_human)
pI: 7.86 Mw: 34149
%vol: 0.229641 %od: 0.685801
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1013.44 (0), 1050.42 (0), 1188.63 (0), 1377.63 (0), 1410.68 (0),
1798.93 (0), 1927.01 (0) }
[Click to access protein entry]
Spot: 2D-001YD0 (lymphocyte_human)
pI: 6.60 Mw: 25815
%vol: 0.160662 %od: 0.0836503
================
*PSB10_HUMAN*
accession n°: P40306
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1130.5751 (0), 1214.6538 (0), 1861.8171 (0), 1947.0312 (0),
2044.0499 (0) }
Spot: 2D-001YD0 (lymphocyte_human)
pI: 6.60 Mw: 25815
%vol: 0.160662 %od: 0.0836503
================
*PSB10_HUMAN*
accession n°: P40306
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1130.5751 (0), 1214.6538 (0), 1861.8171 (0), 1947.0312 (0),
2044.0499 (0) }
[Click to access protein entry]
Spot: 2D-001YCJ (lymphocyte_human)
pI: 6.85 Mw: 26554
%vol: 0.277083 %od: 0.266943
================
*PGAM1_HUMAN*
accession n°: P18669
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1059.5708 (0), 1150.6889 (0), 1312.6147 (0), 2115.0706 (0),
2131.1075 (0) }
Spot: 2D-001YCJ (lymphocyte_human)
pI: 6.85 Mw: 26554
%vol: 0.277083 %od: 0.266943
================
*PGAM1_HUMAN*
accession n°: P18669
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1059.5708 (0), 1150.6889 (0), 1312.6147 (0), 2115.0706 (0),
2131.1075 (0) }
[Click to access protein entry]
Spot: 2D-001YBD (lymphocyte_human)
pI: 4.91 Mw: 29086
%vol: 0.156004 %od: 0.105114
================
*EFHD2_HUMAN*
accession n°: Q96C19
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)AAAGELQEDSGLCVLAR(L);; $m/Z=(R)DGFIDLMoxELK(L);; $m/Z=(R)VFNPYTEFK(E);; $m/Z=(R)ADLNQGIGEPQSPSR(R);; $m/Z=(K)VQAINVSSR(F);; $m/Z=(R)LSEIDVSSEGVK(G) }
Spot: 2D-001YBD (lymphocyte_human)
pI: 4.91 Mw: 29086
%vol: 0.156004 %od: 0.105114
================
*EFHD2_HUMAN*
accession n°: Q96C19
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)AAAGELQEDSGLCVLAR(L);; $m/Z=(R)DGFIDLMoxELK(L);; $m/Z=(R)VFNPYTEFK(E);; $m/Z=(R)ADLNQGIGEPQSPSR(R);; $m/Z=(K)VQAINVSSR(F);; $m/Z=(R)LSEIDVSSEGVK(G) }
[Click to access protein entry]
Spot: 2D-001XZF (lymphocyte_human)
pI: 4.65 Mw: 43614
%vol: 0.352174 %od: 0.299032
================
*PDIA1_HUMAN*
accession n°: P07237
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 870.43532 (0), 905.4054 (0), 910.4519 (0), 1066.4867 (0),
1451.7173 (0), 1459.7071 (0), 1521.7765 (0), 1780.8465 (0),
1833.9008 (0) }
Spot: 2D-001XZF (lymphocyte_human)
pI: 4.65 Mw: 43614
%vol: 0.352174 %od: 0.299032
================
*PDIA1_HUMAN*
accession n°: P07237
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 870.43532 (0), 905.4054 (0), 910.4519 (0), 1066.4867 (0),
1451.7173 (0), 1459.7071 (0), 1521.7765 (0), 1780.8465 (0),
1833.9008 (0) }
[Click to access protein entry]
Spot: 2D-001YA1 (lymphocyte_human)
pI: 5.40 Mw: 32417
%vol: 0.161825 %od: 0.107231
================
*CAZA1_HUMAN*
accession n°: P52907
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 937.449 (0), 1197.6772 (0), 2088.961 (0), 2245.0214 (0)
}
Spot: 2D-001YA1 (lymphocyte_human)
pI: 5.40 Mw: 32417
%vol: 0.161825 %od: 0.107231
================
*CAZA1_HUMAN*
accession n°: P52907
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 937.449 (0), 1197.6772 (0), 2088.961 (0), 2245.0214 (0)
}
[Click to access protein entry]
Spot: 2D-001Y9I (lymphocyte_human)
pI: 5.67 Mw: 33781
%vol: 0.408347 %od: 0.374059
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-001Y9I (lymphocyte_human)
pI: 5.67 Mw: 33781
%vol: 0.408347 %od: 0.374059
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-001Y0I (lymphocyte_human)
pI: 5.06 Mw: 43286
%vol: 0.304441 %od: 0.617604
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)FADLSEAANR(N);; $m/Z=(R)ETNLDSLPLVDTHSK(R);; $m/Z=(R)ISLPLPNFSSLNLR(E);; $m/Z=(R)KLLEGEESR(I);; $m/Z=(K)MALDIEIATYR(K);; $m/Z=(R)EMEENFAVEAANYQDTIGR(L);; $m/Z=(R)QVQSLTCEVDALK(G);; $m/Z=(R)QQYESVAAK(N);; $m/Z=(K)KVESLQEEIAFLK(K);; $m/Z=(R)QDVDNASLARLDLER(K);; $m/Z=(K)LQEEMLQR(E);; $m/Z=(R)LGDLYEEEMR(E);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(K)VELQELNDR(F);; $m/Z=(R)TYSLGSALRPSTSR(S);; $m/Z=(R)SYVTTSTR(T);; $m/Z=(R)SVSSSSYR(R);; $m/Z=(R)DGQVINETSQHHDDLE() }
================
*TBA1B_HUMAN*
accession n: P68363
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)VGINYQPPTVVPGGDLAK(V);; $m/Z=(K)TIGGGDDSFNTFFSETGAGK(H);; $m/Z=(R)QLFHPEQLITGK(E);; $m/Z=(R)LISQIVSSITASLR(F);; $m/Z=(R)IHFPLATYAPVISAEK(A);; $m/Z=(R)SIQFVDWCPTGFK(V) }
Spot: 2D-001Y0I (lymphocyte_human)
pI: 5.06 Mw: 43286
%vol: 0.304441 %od: 0.617604
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)FADLSEAANR(N);; $m/Z=(R)ETNLDSLPLVDTHSK(R);; $m/Z=(R)ISLPLPNFSSLNLR(E);; $m/Z=(R)KLLEGEESR(I);; $m/Z=(K)MALDIEIATYR(K);; $m/Z=(R)EMEENFAVEAANYQDTIGR(L);; $m/Z=(R)QVQSLTCEVDALK(G);; $m/Z=(R)QQYESVAAK(N);; $m/Z=(K)KVESLQEEIAFLK(K);; $m/Z=(R)QDVDNASLARLDLER(K);; $m/Z=(K)LQEEMLQR(E);; $m/Z=(R)LGDLYEEEMR(E);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(K)VELQELNDR(F);; $m/Z=(R)TYSLGSALRPSTSR(S);; $m/Z=(R)SYVTTSTR(T);; $m/Z=(R)SVSSSSYR(R);; $m/Z=(R)DGQVINETSQHHDDLE() }
================
*TBA1B_HUMAN*
accession n: P68363
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)VGINYQPPTVVPGGDLAK(V);; $m/Z=(K)TIGGGDDSFNTFFSETGAGK(H);; $m/Z=(R)QLFHPEQLITGK(E);; $m/Z=(R)LISQIVSSITASLR(F);; $m/Z=(R)IHFPLATYAPVISAEK(A);; $m/Z=(R)SIQFVDWCPTGFK(V) }
[Click to access protein entry]
Spot: 2D-001Y9E (lymphocyte_human)
pI: 6.95 Mw: 33854
%vol: 0.394668 %od: 0.479593
================
*ENOA_HUMAN*
accession n°: P06733
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1143.5926 (0), 1425.6797 (0), 1556.7592 (0), 1804.9472 (0),
1939.978 (0), 1960.9184 (0) }
Spot: 2D-001Y9E (lymphocyte_human)
pI: 6.95 Mw: 33854
%vol: 0.394668 %od: 0.479593
================
*ENOA_HUMAN*
accession n°: P06733
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1143.5926 (0), 1425.6797 (0), 1556.7592 (0), 1804.9472 (0),
1939.978 (0), 1960.9184 (0) }
[Click to access protein entry]
Spot: 2D-001Y9S (lymphocyte_human)
pI: 5.67 Mw: 33200
%vol: 0.311427 %od: 0.197115
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-001Y9S (lymphocyte_human)
pI: 5.67 Mw: 33200
%vol: 0.311427 %od: 0.197115
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-001XX7 (lymphocyte_human)
pI: 4.29 Mw: 44500
%vol: 0.270388 %od: 0.211341
================
*CALR_HUMAN*
accession n°: P27797
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 853.434 (0), 887.3898 (0), 906.4702 (0), 927.4915 (0),
975.4933 (0), 1019.5579 (0), 1045.564 (0), 1047.5083 (0),
1130.5341 (0), 1147.6566 (0), 1219.6814 (0), 1410.6379 (0),
1476.6938 (0), 1607.7465 (0), 1800.8494 (0) }
Spot: 2D-001XX7 (lymphocyte_human)
pI: 4.29 Mw: 44500
%vol: 0.270388 %od: 0.211341
================
*CALR_HUMAN*
accession n°: P27797
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 853.434 (0), 887.3898 (0), 906.4702 (0), 927.4915 (0),
975.4933 (0), 1019.5579 (0), 1045.564 (0), 1047.5083 (0),
1130.5341 (0), 1147.6566 (0), 1219.6814 (0), 1410.6379 (0),
1476.6938 (0), 1607.7465 (0), 1800.8494 (0) }
[Click to access protein entry]
Spot: 2D-001YBH (lymphocyte_human)
pI: 4.66 Mw: 28835
%vol: 0.346644 %od: 0.216642
================
*TPM3_HUMAN*
accession n°: P06753
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 894.44328 (0), 940.43828 (0), 1072.52428 (0), 1156.63528 (0),
1243.65228 (0), 1284.74028 (0), 1316.64028 (0), 1399.76328 (0),
1642.80028 (0), 1770.89728 (0) }
Spot: 2D-001YBH (lymphocyte_human)
pI: 4.66 Mw: 28835
%vol: 0.346644 %od: 0.216642
================
*TPM3_HUMAN*
accession n°: P06753
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 894.44328 (0), 940.43828 (0), 1072.52428 (0), 1156.63528 (0),
1243.65228 (0), 1284.74028 (0), 1316.64028 (0), 1399.76328 (0),
1642.80028 (0), 1770.89728 (0) }
[Click to access protein entry]
Spot: 2D-001Y54 (lymphocyte_human)
pI: 7.10 Mw: 41062
%vol: 0.27388 %od: 0.208279
================
*EFTU_HUMAN*
accession n°: P49411
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)LLDAVDTYIPVPAR(D);; $m/Z=(K)ELAMoxPGEDLK(F);; $m/Z=(R)IILPPEKELAMoxPGEDLK(F);; $m/Z=(R)IILPPEK(E);; $m/Z=(K)VEAQVYILSK(E);; $m/Z=(R)GTVVTGTLER(G) }
Spot: 2D-001Y54 (lymphocyte_human)
pI: 7.10 Mw: 41062
%vol: 0.27388 %od: 0.208279
================
*EFTU_HUMAN*
accession n°: P49411
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)LLDAVDTYIPVPAR(D);; $m/Z=(K)ELAMoxPGEDLK(F);; $m/Z=(R)IILPPEKELAMoxPGEDLK(F);; $m/Z=(R)IILPPEK(E);; $m/Z=(K)VEAQVYILSK(E);; $m/Z=(R)GTVVTGTLER(G) }
[Click to access protein entry]
Spot: 2D-001YCL (lymphocyte_human)
pI: 5.40 Mw: 26439
%vol: 0.261947 %od: 0.162569
================
*PHB_HUMAN*
accession n°: P35232
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1058.5842 (0), 1149.6272 (0), 1185.6994 (0), 1396.8822 (0),
1444.6952 (0), 1606.8848 (0), 1998.1261 (0) }
Spot: 2D-001YCL (lymphocyte_human)
pI: 5.40 Mw: 26439
%vol: 0.261947 %od: 0.162569
================
*PHB_HUMAN*
accession n°: P35232
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1058.5842 (0), 1149.6272 (0), 1185.6994 (0), 1396.8822 (0),
1444.6952 (0), 1606.8848 (0), 1998.1261 (0) }
[Click to access protein entry]
Spot: 2D-001YER (lymphocyte_human)
pI: 5.39 Mw: 20864
%vol: 0.0928459 %od: 0.0801529
================
*APT_HUMAN*
accession n°: P07741
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 885.4662 (0), 1122.5808 (0), 1444.7787 (0), 1465.7419 (0)
}
Spot: 2D-001YER (lymphocyte_human)
pI: 5.39 Mw: 20864
%vol: 0.0928459 %od: 0.0801529
================
*APT_HUMAN*
accession n°: P07741
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 885.4662 (0), 1122.5808 (0), 1444.7787 (0), 1465.7419 (0)
}
[Click to access protein entry]
Spot: 2D-001YDX (lymphocyte_human)
pI: 5.43 Mw: 23712
%vol: 0.347808 %od: 0.220126
================
*GSTP1_HUMAN*
accession n°: P09211
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1337.7509 (0), 1883.9496 (0), 2116.9846 (0), 2126.166 (0),
2132.9847 (0), 2155.0385 (0) }
Spot: 2D-001YDX (lymphocyte_human)
pI: 5.43 Mw: 23712
%vol: 0.347808 %od: 0.220126
================
*GSTP1_HUMAN*
accession n°: P09211
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1337.7509 (0), 1883.9496 (0), 2116.9846 (0), 2126.166 (0),
2132.9847 (0), 2155.0385 (0) }
[Click to access protein entry]
Spot: 2D-001YFH (lymphocyte_human)
pI: 7.31 Mw: 17780
%vol: 0.016881 %od: 0.0117582
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1055.5352 (0), 1154.5587 (0), 1247.6071 (0), 1310.5507 (0),
1379.7348 (0), 1423.735 (0), 1537.7165 (0), 1614.7363 (0),
1831.906 (0), 1946.0415 (0) }
Spot: 2D-001YFH (lymphocyte_human)
pI: 7.31 Mw: 17780
%vol: 0.016881 %od: 0.0117582
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1055.5352 (0), 1154.5587 (0), 1247.6071 (0), 1310.5507 (0),
1379.7348 (0), 1423.735 (0), 1537.7165 (0), 1614.7363 (0),
1831.906 (0), 1946.0415 (0) }
[Click to access protein entry]
Spot: 2D-001YC6 (lymphocyte_human)
pI: 5.52 Mw: 27491
%vol: 0.0756738 %od: 0.0550851
================
*3HIDH_HUMAN*
accession n°: P31937
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)TPVGFIGLGNMoxGNPMoxAK(N);; $m/Z=(K)EFQDAGEQVVSSPADVAEK(A);; $m/Z=(K)DLGLAQDSATSTK(S);; $m/Z=(K)MoxGAVFMoxDAPVSGGVGAAR(S);; $m/Z=(K)MGAVFMDAPVSGGVGAAR(S) }
Spot: 2D-001YC6 (lymphocyte_human)
pI: 5.52 Mw: 27491
%vol: 0.0756738 %od: 0.0550851
================
*3HIDH_HUMAN*
accession n°: P31937
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)TPVGFIGLGNMoxGNPMoxAK(N);; $m/Z=(K)EFQDAGEQVVSSPADVAEK(A);; $m/Z=(K)DLGLAQDSATSTK(S);; $m/Z=(K)MoxGAVFMoxDAPVSGGVGAAR(S);; $m/Z=(K)MGAVFMDAPVSGGVGAAR(S) }
[Click to access protein entry]
Spot: 2D-001YE5 (lymphocyte_human)
pI: 5.99 Mw: 23159
%vol: 0.104488 %od: 0.041886
================
*ABHEB_HUMAN*
accession n°: Q96IU4
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)AVAIDLPGLGHSK(E);; $m/Z=(R)FSSETWQNLGTLHR(L);; $m/Z=(R)FSVLLLHGIR(F);; $m/Z=(R)EGTIQVQGQALFFR(E) }
Spot: 2D-001YE5 (lymphocyte_human)
pI: 5.99 Mw: 23159
%vol: 0.104488 %od: 0.041886
================
*ABHEB_HUMAN*
accession n°: Q96IU4
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)AVAIDLPGLGHSK(E);; $m/Z=(R)FSSETWQNLGTLHR(L);; $m/Z=(R)FSVLLLHGIR(F);; $m/Z=(R)EGTIQVQGQALFFR(E) }
[Click to access protein entry]
Spot: 2D-001YEJ (lymphocyte_human)
pI: 5.41 Mw: 22317
%vol: 0.22935 %od: 0.128305
================
*PRDX2_HUMAN*
accession n°: P32119
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 862.50838 (0), 924.46007 (0), 972.54725 (0), 978.50386 (0),
1023.5095 (0), 1179.6358 (0), 1211.6889 (0), 1734.985 (0),
1863.0792 (0) }
Spot: 2D-001YEJ (lymphocyte_human)
pI: 5.41 Mw: 22317
%vol: 0.22935 %od: 0.128305
================
*PRDX2_HUMAN*
accession n°: P32119
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 862.50838 (0), 924.46007 (0), 972.54725 (0), 978.50386 (0),
1023.5095 (0), 1179.6358 (0), 1211.6889 (0), 1734.985 (0),
1863.0792 (0) }
[Click to access protein entry]
Spot: 2D-001YCA (lymphocyte_human)
pI: 5.48 Mw: 27195
%vol: 0.15193 %od: 0.126061
================
*CAPZB_HUMAN*
accession n°: P47756
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1057.59928 (0), 1108.63728 (0), 1171.58028 (0), 1231.54828 (0),
1534.67928 (0), 1568.71428 (0), 1696.82928 (0)
}
Spot: 2D-001YCA (lymphocyte_human)
pI: 5.48 Mw: 27195
%vol: 0.15193 %od: 0.126061
================
*CAPZB_HUMAN*
accession n°: P47756
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1057.59928 (0), 1108.63728 (0), 1171.58028 (0), 1231.54828 (0),
1534.67928 (0), 1568.71428 (0), 1696.82928 (0)
}
[Click to access protein entry]
Spot: 2D-001Y4T (lymphocyte_human)
pI: 5.29 Mw: 41600
%vol: 0.503522 %od: 0.992934
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-001Y4T (lymphocyte_human)
pI: 5.29 Mw: 41600
%vol: 0.503522 %od: 0.992934
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-001YA9 (lymphocyte_human)
pI: 5.38 Mw: 32068
%vol: 0.278829 %od: 0.217179
================
*CAZA1_HUMAN*
accession n°: P52907
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 937.449 (0), 1197.6772 (0), 2088.961 (0), 2245.0214 (0)
}
Spot: 2D-001YA9 (lymphocyte_human)
pI: 5.38 Mw: 32068
%vol: 0.278829 %od: 0.217179
================
*CAZA1_HUMAN*
accession n°: P52907
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 937.449 (0), 1197.6772 (0), 2088.961 (0), 2245.0214 (0)
}
[Click to access protein entry]
Spot: 2D-001YEO (lymphocyte_human)
pI: 7.76 Mw: 21614
%vol: 0.140579 %od: 0.09514
================
*PEBP1_HUMAN*
accession n°: P30086
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1454.699 (0), 1559.825 (0), 1631.814 (0), 1707.901 (0),
1773.862 (0), 2068.95 (0), 3470.687 (0) }
Spot: 2D-001YEO (lymphocyte_human)
pI: 7.76 Mw: 21614
%vol: 0.140579 %od: 0.09514
================
*PEBP1_HUMAN*
accession n°: P30086
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1454.699 (0), 1559.825 (0), 1631.814 (0), 1707.901 (0),
1773.862 (0), 2068.95 (0), 3470.687 (0) }
[Click to access protein entry]
Spot: 2D-001YCY (lymphocyte_human)
pI: 6.79 Mw: 25871
%vol: 0.158042 %od: 0.105002
================
*PSA6_HUMAN*
accession n°: P60900
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1156.6144 (0), 1160.5792 (0), 1285.7352 (0), 1360.7116 (0),
1979.0477 (0) }
Spot: 2D-001YCY (lymphocyte_human)
pI: 6.79 Mw: 25871
%vol: 0.158042 %od: 0.105002
================
*PSA6_HUMAN*
accession n°: P60900
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1156.6144 (0), 1160.5792 (0), 1285.7352 (0), 1360.7116 (0),
1979.0477 (0) }
[Click to access protein entry]
Spot: 2D-001Y95 (lymphocyte_human)
pI: 8.02 Mw: 34002
%vol: 0.351301 %od: 1.41754
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 912.3925 (0), 1013.4416 (0), 1050.4377 (0), 1165.5331 (0),
1188.6545 (0), 1338.7199 (0), 1377.6368 (0), 1695.7759 (0),
1798.9199 (0), 1927.014 (0), 2189.944 (0), 2205.93 (0)
}
Spot: 2D-001Y95 (lymphocyte_human)
pI: 8.02 Mw: 34002
%vol: 0.351301 %od: 1.41754
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 912.3925 (0), 1013.4416 (0), 1050.4377 (0), 1165.5331 (0),
1188.6545 (0), 1338.7199 (0), 1377.6368 (0), 1695.7759 (0),
1798.9199 (0), 1927.014 (0), 2189.944 (0), 2205.93 (0)
}
[Click to access protein entry]
Spot: 2D-001Y1U (lymphocyte_human)
pI: 4.62 Mw: 42853
%vol: 0.198207 %od: 0.102947
================
*LSP1_HUMAN*
accession n°: P33241
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1647.8418 (0), 1974.9857 (0), 1977.9033 (0), 2022.001 (0),
2064.9292 (0), 2864.1504 (0) }
Spot: 2D-001Y1U (lymphocyte_human)
pI: 4.62 Mw: 42853
%vol: 0.198207 %od: 0.102947
================
*LSP1_HUMAN*
accession n°: P33241
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1647.8418 (0), 1974.9857 (0), 1977.9033 (0), 2022.001 (0),
2064.9292 (0), 2864.1504 (0) }
[Click to access protein entry]
Spot: 2D-001YF4 (lymphocyte_human)
pI: 7.95 Mw: 18389
%vol: 0.465394 %od: 1.62247
================
*COF1_HUMAN*
accession n°: P23528
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 876.42 (0), 1050.5 (0), 1309.7 (0), 1337.7 (0), 1340.76 (0),
1519.69 (0), 1790.86 (0), 1990.07 (0), 2166.09 (0)
}
Spot: 2D-001YF4 (lymphocyte_human)
pI: 7.95 Mw: 18389
%vol: 0.465394 %od: 1.62247
================
*COF1_HUMAN*
accession n°: P23528
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 876.42 (0), 1050.5 (0), 1309.7 (0), 1337.7 (0), 1340.76 (0),
1519.69 (0), 1790.86 (0), 1990.07 (0), 2166.09 (0)
}
[Click to access protein entry]
Spot: 2D-001YC7 (lymphocyte_human)
pI: 5.64 Mw: 27372
%vol: 0.145817 %od: 0.1016
================
*PSME1_HUMAN*
accession n°: Q06323
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)QLVHELDEAEYR(D);; $m/Z=(K)QPHVGDYR(Q);; $m/Z=(K)IVVLLQR(L);; $m/Z=(K)LEGFHTQISK(Y) }
Spot: 2D-001YC7 (lymphocyte_human)
pI: 5.64 Mw: 27372
%vol: 0.145817 %od: 0.1016
================
*PSME1_HUMAN*
accession n°: Q06323
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)QLVHELDEAEYR(D);; $m/Z=(K)QPHVGDYR(Q);; $m/Z=(K)IVVLLQR(L);; $m/Z=(K)LEGFHTQISK(Y) }
[Click to access protein entry]
Spot: 2D-001YG6 (lymphocyte_human)
pI: 5.27 Mw: 16317
%vol: 0.0451132 %od: 0.029028
================
*SH3L1_HUMAN*
accession n°: O75368
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1159.5898 (0), 1190.5125 (0), 1848.9669 (0), 3003.4913 (0)
}
Spot: 2D-001YG6 (lymphocyte_human)
pI: 5.27 Mw: 16317
%vol: 0.0451132 %od: 0.029028
================
*SH3L1_HUMAN*
accession n°: O75368
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1159.5898 (0), 1190.5125 (0), 1848.9669 (0), 3003.4913 (0)
}
[Click to access protein entry]
Spot: 2D-001YFJ (lymphocyte_human)
pI: 4.26 Mw: 17661
%vol: 0.0456953 %od: 0.0251418
================
*CALM_HUMAN*
accession n°: P62158
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.49 (0), 1265.64 (0), 1596.72 (0), 1754.88 (0), 1844.9 (0)
}
Spot: 2D-001YFJ (lymphocyte_human)
pI: 4.26 Mw: 17661
%vol: 0.0456953 %od: 0.0251418
================
*CALM_HUMAN*
accession n°: P62158
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.49 (0), 1265.64 (0), 1596.72 (0), 1754.88 (0), 1844.9 (0)
}
[Click to access protein entry]
Spot: 2D-001YE4 (lymphocyte_human)
pI: 6.44 Mw: 23198
%vol: 0.157459 %od: 0.13814
================
*PRDX3_HUMAN*
accession n°: P30048
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)HLSVNDLPVGR(S);; $m/Z=(R)DYGVLLEGSGLALR(G) }
Spot: 2D-001YE4 (lymphocyte_human)
pI: 6.44 Mw: 23198
%vol: 0.157459 %od: 0.13814
================
*PRDX3_HUMAN*
accession n°: P30048
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)HLSVNDLPVGR(S);; $m/Z=(R)DYGVLLEGSGLALR(G) }
[Click to access protein entry]
Spot: 2D-001YGA (lymphocyte_human)
pI: 4.74 Mw: 16099
%vol: 0.0555911 %od: 0.0396992
================
*THIO_HUMAN*
accession n°: P10599
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)TAFQEALDAAGDK(L) }
================
*H4_HUMAN*
accession n: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)TVTAMoxDVVYALK(R);; $m/Z=(R)ISGLIYEETR(G) }
Spot: 2D-001YGA (lymphocyte_human)
pI: 4.74 Mw: 16099
%vol: 0.0555911 %od: 0.0396992
================
*THIO_HUMAN*
accession n°: P10599
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)TAFQEALDAAGDK(L) }
================
*H4_HUMAN*
accession n: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)TVTAMoxDVVYALK(R);; $m/Z=(R)ISGLIYEETR(G) }
[Click to access protein entry]
Spot: 2D-001Y0D (lymphocyte_human)
pI: 4.94 Mw: 43308
%vol: 0.20723 %od: 0.20267
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)FLEQQNK(I);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(R)QDVDNASLAR(L);; $m/Z=(K)KVESLQEEIAFLK(K) }
Spot: 2D-001Y0D (lymphocyte_human)
pI: 4.94 Mw: 43308
%vol: 0.20723 %od: 0.20267
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(R)FLEQQNK(I);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(R)QDVDNASLAR(L);; $m/Z=(K)KVESLQEEIAFLK(K) }
[Click to access protein entry]
Spot: 2D-001Y2J (lymphocyte_human)
pI: 4.83 Mw: 42552
%vol: 0.0838233 %od: 0.107765
================
*TBB5_HUMAN*
accession n°: P07437
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1028.5099 (0), 1077.5322 (0), 1130.6085 (0), 1143.623 (0),
1159.616 (0), 1615.8306 (0), 1958.9764 (0) }
Spot: 2D-001Y2J (lymphocyte_human)
pI: 4.83 Mw: 42552
%vol: 0.0838233 %od: 0.107765
================
*TBB5_HUMAN*
accession n°: P07437
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1028.5099 (0), 1077.5322 (0), 1130.6085 (0), 1143.623 (0),
1159.616 (0), 1615.8306 (0), 1958.9764 (0) }
[Click to access protein entry]
Spot: 2D-001YH6 (lymphocyte_human)
pI: 4.18 Mw: 30178
================
*AN32A_HUMAN*
accession n°: P39687
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 936.55632 (0), 945.49173 (0), 974.51148 (0), 1101.6071 (0),
1566.8482 (0), 1924.9984 (0), 1972.95 (0) }
Spot: 2D-001YH6 (lymphocyte_human)
pI: 4.18 Mw: 30178
================
*AN32A_HUMAN*
accession n°: P39687
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 936.55632 (0), 945.49173 (0), 974.51148 (0), 1101.6071 (0),
1566.8482 (0), 1924.9984 (0), 1972.95 (0) }
[Click to access protein entry]
Spot: 2D-001YBM (lymphocyte_human)
pI: 5.00 Mw: 28462
%vol: 0.136504 %od: 0.0825762
================
*EFHD2_HUMAN*
accession n°: Q96C19
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)AAAGELQEDSGLCVLAR(L);; $m/Z=(R)LSEIDVSSEGVK(G);; $m/Z=(R)ADLNQGIGEPQSPSR(R);; $m/Z=(R)DGFIDLMoxELK(L) }
Spot: 2D-001YBM (lymphocyte_human)
pI: 5.00 Mw: 28462
%vol: 0.136504 %od: 0.0825762
================
*EFHD2_HUMAN*
accession n°: Q96C19
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
$m/Z=(K)AAAGELQEDSGLCVLAR(L);; $m/Z=(R)LSEIDVSSEGVK(G);; $m/Z=(R)ADLNQGIGEPQSPSR(R);; $m/Z=(R)DGFIDLMoxELK(L) }
 |
SWISS-2DPAGE Viewer
|
Back to the search engine |
-Get more information by dragging your mouse pointer over any highlighted spot -Click on a highlighted spot to access all its associated protein entries
Back to the
search engine